“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: Inhibition of TAFI and PAI-1 protects mice from cerebral ischemia/reperfusion injury

€3.03

SKU: product-article-19208 Category: General

Description
Reviews (0)

Description

Inhibition of TAFI and PAI-1 protects mice from cerebral ischemia/reperfusion injury

Reviews

There are no reviews yet.

Be the first to review “Article: Inhibition of TAFI and PAI-1 protects mice from cerebral ischemia/reperfusion injury”

You must be logged in to post a review.

Top

Article: Inhibition of TAFI and PAI-1 protects mice from cerebral ischemia/reperfusion injury

Description

Reviews

Related products

Article: Highlights in respiratory oncology

Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma

Article: Highlights in squamous cell carcinoma of the head and neck

Article: Highlights in squamous cell carcinoma of the head and neck